Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (411-420 of 753) with videos related to

Pageof 76
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group)V Spataro, K Price, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesM Colleoni, N Rotmensz, G Peruzzotti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1993
The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG)C Hürny, J Bernhard, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Marco Colleoni, Shari Gelber, et al.
The Breast Journal|October 13, 2012
Do early breast cancer patients with only sentinel lymph node biopsy experience lower psychological morbidity over time?Florence Didier, Davide Radice, Andrea Maldifassi, et al.
Clinical Breast Cancer|December 15, 2010
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancerRosalba Torrisi, Anna Cardillo, Giuseppe Cancello, et al.
Breast Cancer Research and Treatment|January 12, 2011
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancerRosalba Torrisi, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combinationC Catania, M Medici, E Magni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2005
Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotypeL Orlando, G Renne, A Rocca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer ResearchM Borner, M Bacchi, A Goldhirsch, et al.
Pageof 76

Showing results (411-420 of 753) with videos related to

Sort By:
Pageof 76
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group)V Spataro, K Price, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesM Colleoni, N Rotmensz, G Peruzzotti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1993
The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG)C Hürny, J Bernhard, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Marco Colleoni, Shari Gelber, et al.
The Breast Journal|October 13, 2012
Do early breast cancer patients with only sentinel lymph node biopsy experience lower psychological morbidity over time?Florence Didier, Davide Radice, Andrea Maldifassi, et al.
Clinical Breast Cancer|December 15, 2010
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancerRosalba Torrisi, Anna Cardillo, Giuseppe Cancello, et al.
Breast Cancer Research and Treatment|January 12, 2011
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancerRosalba Torrisi, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combinationC Catania, M Medici, E Magni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2005
Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotypeL Orlando, G Renne, A Rocca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer ResearchM Borner, M Bacchi, A Goldhirsch, et al.
Pageof 76